Tunitas wins SBIR phase II grant to progress asthma program
Aimed at advancing the company’s first clinical candidate into preclinical studies, the three-year grant will particularly support non-human primate efficacy studies, mechanism of action experiments, and discovery of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.